1. Home
  2. ARWR vs NMIH Comparison

ARWR vs NMIH Comparison

Compare ARWR & NMIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • NMIH
  • Stock Information
  • Founded
  • ARWR 2003
  • NMIH 2011
  • Country
  • ARWR United States
  • NMIH United States
  • Employees
  • ARWR 525
  • NMIH N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • NMIH Property-Casualty Insurers
  • Sector
  • ARWR Health Care
  • NMIH Finance
  • Exchange
  • ARWR Nasdaq
  • NMIH Nasdaq
  • Market Cap
  • ARWR 2.7B
  • NMIH 3.2B
  • IPO Year
  • ARWR 1993
  • NMIH 2013
  • Fundamental
  • Price
  • ARWR $22.04
  • NMIH $37.54
  • Analyst Decision
  • ARWR Buy
  • NMIH Buy
  • Analyst Count
  • ARWR 12
  • NMIH 7
  • Target Price
  • ARWR $42.70
  • NMIH $43.14
  • AVG Volume (30 Days)
  • ARWR 2.0M
  • NMIH 453.3K
  • Earning Date
  • ARWR 02-04-2025
  • NMIH 02-12-2025
  • Dividend Yield
  • ARWR N/A
  • NMIH N/A
  • EPS Growth
  • ARWR N/A
  • NMIH 18.41
  • EPS
  • ARWR N/A
  • NMIH 4.37
  • Revenue
  • ARWR $3,551,000.00
  • NMIH $635,847,000.00
  • Revenue This Year
  • ARWR $4,225.26
  • NMIH N/A
  • Revenue Next Year
  • ARWR $59.48
  • NMIH $7.13
  • P/E Ratio
  • ARWR N/A
  • NMIH $8.71
  • Revenue Growth
  • ARWR N/A
  • NMIH 13.40
  • 52 Week Low
  • ARWR $17.05
  • NMIH $28.59
  • 52 Week High
  • ARWR $39.83
  • NMIH $42.49
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 50.44
  • NMIH 42.88
  • Support Level
  • ARWR $21.48
  • NMIH $37.49
  • Resistance Level
  • ARWR $22.47
  • NMIH $38.66
  • Average True Range (ATR)
  • ARWR 1.27
  • NMIH 0.82
  • MACD
  • ARWR -0.23
  • NMIH -0.14
  • Stochastic Oscillator
  • ARWR 12.63
  • NMIH 19.83

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

About NMIH NMI Holdings Inc.

NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.

Share on Social Networks: